Actively Recruiting
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
Led by University of Alberta · Updated on 2026-05-11
600
Participants Needed
1
Research Sites
341 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Somatostatin receptor (SSR) imaging is a critical component of clinical care for many patients being investigated for or with confirmed SSR positive tumors. In the past, 111In-octreotide imaging has been used for this purpose but it has been recently supplanted globally by SSR positron emission tomography (PET) imaging due to better image quality and higher diagnostic accuracy. This study will assess the safety and diagnostic effectiveness of 68Ga-HA-DOTATATE produced a the Edmonton Radiopharmaceutical Centre (ERC).
CONDITIONS
Official Title
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with known or clinically suspected somatostatin receptor positive tumors such as gastrointestinal, pancreatic, pulmonary neuroendocrine tumors, pheochromocytoma, paraganglioma, medullary thyroid cancer, medulloblastoma, or meningioma
- Standard clinical CT or MRI scan obtained within 6 months before enrollment
- Ability to provide written informed consent (participant or legal medical decision maker)
You will not qualify if you...
- Weight over 225 kg (scanner weight limit)
- Unable to undergo scanning due to extreme claustrophobia or inability to lie still
- Any medical condition or serious illness that may interfere with study conduct or results
- Previous allergic reaction to DOTATATE or somatostatin analogues
- No intravenous access
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2B7
Actively Recruiting
Research Team
J
Jonathan Abele, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here